Publication|Articles|March 19, 2026
- Pharmaceutical Executive: March 2026
- Volume 46
- Issue 2
Pharmaceutical Executive: March 2026 Interactive Digital Edition
View the Pharmaceutical Executive March 2026 issue in an interactive format.
Advertisement
Click
Articles in this issue
4 months ago
Data and Trust5 months ago
Andrew Hall: The Discipline of Conviction5 months ago
Cautious Momentum: Biopharma Review and Outlook5 months ago
Orphan Product Risk ContractingAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
How MBA Graduates Can Break into Competitive Industries in 2026: 4 Practical Steps
2
FDA Approves Otsuka’s First-In-Class Simtriyo for Adults & Pediatric Patients
3
Pharma M&A Roundup: Oak Hill Bio Combines with RACC, Apnimed Plans $150 Million IPO, CORE Biomedicine Secures $21 Million Series A
4
Moving From Symptom Management to Disease Modification in Parkinson’s Research: Q&A with Dr. Jan Stoehr
5
